Analogs of M4 selective synthetic muscarinic receptor antagonists: Synthesis, binding and pharmacokinetic properties

Medicinal Chemistry Research

Volumn 11, Issue 8, 2002, Pages 423-433

  Böhme, Thomas M ^a   Augelli Szafran, Corinne E ^a   Hallak, Hussein ^a   Schwarz, Roy D ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 ETHYL 9 METHOXY 6,11,12,13 TETRAHYDRO 3H,6AH,3,12A DIAZABENZO[A]CYCLOPENTA[H]ANTHRACENE 1 CARBOXYLIC ACID ETHYL ESTER; 5 BROMO 2 ETHYL 9 METHOXY 6,11,12,13 TETRAHYDRO 3H,6AH,3,12A DIAZABENZO[A]CYCLOPENTA[H]ANTHRACENE 1 CARBOXYLIC ACID ETHYL ESTER; ESTER DERIVATIVE; MUSCARINIC RECEPTOR BLOCKING AGENT; PD 0298029; PD 0320115; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; BIOAVAILABILITY; CONTROLLED STUDY; DRUG CLEARANCE; DRUG METABOLISM; DRUG SENSITIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; IN VIVO STUDY; MALE; NONHUMAN; RAT; RECEPTOR BINDING;

EID: 0042331039     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Eglen, R. M.; Choppin, A.; Dillon, M. P.; Hedge, S. Curr. Opin. Chem. Biol. 1999, 3, 426-432.
2. Caulfield, M. P. Pharmacol. Ther. 1993, 58, 319-379.
3. Olianas, M. C.; Onali, P. Life Sci. 1999, 61, 2233-2240.
4. Izurieta-Sanchez, P.; Sarre, S.; Ebinger, G.; Michotte, Y. Eur. J. Pharmacol. 2000, 399, 151-160.
5. Böhme, T. M.; Augelli-Szafran, C. E.; Hallak, H.; Pugsley, T.; Serpa, K.; Schwarz, R. D. J. Med. Chem. 2002, 45, 3094-3102.
6. Buckley, N. J.; Bonner, T. I.; Buckley, C. M.; Brann, M. R. Mol. Pharmacol. 1989, 35, 469-476.
7. Dörje, F.; Wess, J.; Lambrecht, G.; Tacke, R., Mutschler, E.; Brann, M. R. J. Pharmacol. Exp. Ther. 1991, 256, 727-733.
8. Bischler, A.; Napieralski, B. Chem. Ber. 1893, 26, 1903.
9. Harmon, A. D.; Hutchinson, C. R. J. Org. Chem. 1975, 40(24), 3474-3480.
10. Augelli-Szafran, C. E.; Jaen, J. C.; Moreland, D. W.; Nelson, C. B.; Penvose-Yi, J. R.; Schwarz, R. D. Bioorg. Med. Chem. Lett. 1998, 8, 1991-1996.